PW Medtech Group Limited (01358) released a Next Day Disclosure Return dated 20 February 2026, confirming that its total number of issued shares remains at 1.47 billion. The company also disclosed the ongoing status of its share repurchase program, highlighting multiple repurchases that have not yet been cancelled.

According to the announcement, a further 53,000 shares were repurchased on 20 February 2026 at prices ranging from HKD1.34 to HKD1.35, resulting in an aggregate payment of HKD71,380. Under a repurchase mandate dated 10 June 2025, the company is authorized to repurchase up to 148.67 million shares; as of the latest update, 18.49 million shares (approximately 1.24% of the issued share base at the time of the resolution) have been repurchased. The announcement also notes a moratorium on any new share issuance until 22 March 2026.